Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days 1.22€ 1.22€ Friday, 22nd Dec 2023 PHGN.F stock ended at 1.22€. During the day the stock fluctuated 0% from a day low at 1.22€ to a day high of 1.22€.
90 days 1.20€ 1.22€
52 weeks 0.92€ 1.48€

Historical Pharming Group N.V. prices

Date Open High Low Close Volume
Jun 30, 2023 1.07€ 1.07€ 1.07€ 1.07€ 0
Jun 29, 2023 1.07€ 1.07€ 1.07€ 1.07€ 0
Jun 28, 2023 1.04€ 1.08€ 1.04€ 1.06€ 1 920
Jun 27, 2023 1.04€ 1.04€ 1.04€ 1.04€ 0
Jun 26, 2023 1.05€ 1.05€ 1.05€ 1.05€ 0
Jun 23, 2023 1.07€ 1.07€ 1.07€ 1.07€ 0
Jun 22, 2023 1.06€ 1.06€ 1.06€ 1.06€ 0
Jun 21, 2023 1.07€ 1.07€ 1.07€ 1.07€ 0
Jun 20, 2023 1.07€ 1.07€ 1.07€ 1.07€ 0
Jun 19, 2023 1.08€ 1.08€ 1.08€ 1.08€ 0
Jun 16, 2023 1.10€ 1.10€ 1.10€ 1.10€ 0
Jun 15, 2023 1.12€ 1.12€ 1.12€ 1.12€ 0
Jun 14, 2023 1.14€ 1.14€ 1.14€ 1.14€ 0
Jun 13, 2023 1.15€ 1.17€ 1.15€ 1.15€ 200
Jun 12, 2023 1.10€ 1.14€ 1.10€ 1.14€ 0
Jun 09, 2023 1.09€ 1.10€ 1.09€ 1.10€ 0
Jun 08, 2023 1.09€ 1.09€ 1.09€ 1.09€ 240
Jun 07, 2023 1.12€ 1.12€ 1.12€ 1.12€ 0
Jun 06, 2023 1.10€ 1.10€ 1.10€ 1.10€ 0
Jun 05, 2023 1.13€ 1.13€ 1.13€ 1.13€ 0
Jun 02, 2023 1.15€ 1.15€ 1.13€ 1.13€ 0
Jun 01, 2023 1.13€ 1.14€ 1.13€ 1.14€ 0
May 31, 2023 1.14€ 1.15€ 1.14€ 1.15€ 0
May 30, 2023 1.18€ 1.18€ 1.17€ 1.17€ 0
May 29, 2023 1.17€ 1.17€ 1.17€ 1.17€ 0
Click to get the best stock tips daily for free!

About Pharming Group N.V.

Pharming Group N.V. Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment ... PHGN.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT